Health

Information on policies, strategy and funding in health research and innovation

News Highlights

11 January 2018

Long-term outcomes of NEuroSIS study published in New England Journal of Medicine

The FP7 funded project Neonatal European Study of Inhaled Steroids (NEuroSIS) is a randomized, placebo-controlled international multicentre clinical trial and focuses on preterm infants born at less than 28 weeks of gestational age and the main objective was to determine whether the early inhalation of budesonide reduces the risk of mortality and bronchopulmonary dysplasia. The results of NEuroSIS provided useful indications about the efficacy and safety of inhaled steroids in very preterm infants. Today, NEuroSIS has published an article on long-term effects of inhaled budesonide for bronchopulmonary dysplasia in the New England Journal of Medicine.

More information


9 January 2018

Juncker Plan supports cancer research with €40 million loan to Indivumed

The European Investment Bank is providing a loan of €40 million to Indivumed GmbH. The new funding will allow this German company to continue its development of a global database, supporting the work of cancer researchers by providing access to data from cancer patients, as well as investing in the latest technology to better understand complex cancer data. The financing for this project is guaranteed by the European Fund for Strategic Investments, the central pillar of the Investment Plan for Europe.

More information


21 December 2017

Launch of the Public Consultation on Vaccination – have your say!

Today, the European Commission is officially launching the Public Consultation on strengthened cooperation against vaccine preventable diseases. The objectives of the consultation will be to collect views from the general public and stakeholders on three main aspects of vaccination: addressing vaccine hesitancy and improving vaccination coverage, achieving sustainable vaccine policies in the EU and improving EU coordination, promoting stakeholders dialogue and contributing to global health. Vaccination is the main tool for primary prevention of disease. Misconceptions about vaccination have shifted the public focus away from the individual and collective benefits of vaccination to increased distrust of science and fear of possible side effects.

More information


20 December 2017

EU-funded project BATCure to tackle the Batten disease

Batten disease is a fatal, inherited disorder of the nervous system that typically begins in childhood. The goal of Horizon 2020 project BATCure is to advance the development of new therapeutic options for a group of rare lysosomal diseases or Batten disease. The project aims to create new models, tools and technologies for developing and testing therapies.

More information


19 December 2017

EU-funded project U-PGx wants to make treatment optimization accessible to everyone

The U-PGx consortium addresses major challenges and obstacles for implementation of PGx testing in patient care, taking into account the diversity of healthcare systems and citizens across Europe. Specifically, U-PGx will investigate if the emerging approach of pre-emptive genotyping of an entire panel of important PGx markers is cost-effective and results in a better outcome for patients. The project combines existing pharmacogenomics guidelines and novel health IT solutions.

More information


18 December 2017

Health Info Day 2017 – presentations available now

In the framework of the Health Info Day, the Horizon 2020 Work Programme 2018-2020 for Societal Challenge 1 was presented and the participants were informed about the topics, deadlines and process of the next calls for proposals. All presentations and video recording are now online.

More information


More News Headlines

 

 

Success Stories

Read more Success Stories

Upcoming Events

30 January 2018, Brussels, Belgium - Message from Alliance4Life

15-16 March 2018, Düsseldorf, Germany - Successful R&I in Europe 2018 - 9th European Networking Event

More Events

Social Corner

twitter logo

Follow us on Twitter


Facebook logo Find us on Facebook on the EU Science & Innovation page page